L-Phenylalaninamide, N-(mercaptoacetyl)-L-leucyl-N-methyl-

CAS No: 169812-23-1

Order 169812-23-1

16981-80-9 (3aR)-2,3,3a,4,5,6,7,8-Octahydro-4α,9,9-trimethyl-3a,7β-methanoazulene-1-methanol

169812-23-1 L-Phenylalaninamide, N-(mercaptoacetyl)-L-leucyl-N-methyl-

16980-32-8 Sulfonium, dimethyl-, 1-(ethoxycarbonyl)-2-oxo-2-(phenylamino)ethylide

169798-41-8 4-(1-Amino-4-naphthylazo)diphenyl

169798-10-1 4,11-Dibutyldibenzo[a,rst]naphtho[8,1,2-cde]pentaphene

169827-16-1 Benzoic acid, 4-(1-hydroxy-2-methyl-3-butenyl)-, methyl ester

169814-55-5 Ethanone, 1-[3-(4-fluorophenyl)-5-Methyl-4-isoxazolyl]-

16981-97-8 (3aS)-3a,5,5a,9,9aβ,9bα-Hexahydro-9β-hydroxy-5aα,9-dimethyl-3-methylenenaphtho[1,2-b]furan-2,6(3H,4H)-dione

1698-24-4 Benzene, 1-chloro-4-[chloro(4-methylphenyl)methyl]-

169798-07-6 4,4-Bis[2-[2-chloro-5-(o-methylphenylcarbamoyl)phenylazo]acetoacetylamino]-3,3-dimethylbiphenyl

169798-08-7 4,4-(Acetoaceto-2-methyl-5-chloroanilid-2-yl-azo)-3,3-dichlorodiphenyl

169809-64-7 Propanedioic acid, methyl(2-phenyl-2-propenyl)-, diethyl ester

169822-47-3 Cyclohexanone, 4-(4-cyclohexylidenecyclohexylidene)-

169802-84-0 Enlimomab pegol

169813-63-2 3,7,9-Trioxa-1-azaspiro[4.5]dec-1-ene, 2-(2,6-dichlorophenyl)-8-phenyl-

169815-49-0 1,2-Ethanediamine, N,N-diethyl-N'-[7-(trifluoromethyl)-4-quinolinyl]-

16980-85-1 1-Pentacosene

169814-25-9 1,2-Benzisoxazol-4(5H)-one, 6,7-dihydro-3-(3-methoxyphenyl)-

169827-91-2 1H-Pyrido[3,4-b]indole, 2,3,4,9-tetrahydro-1-(2-thienyl)-

169815-81-0 FURO[2,3-B]PYRIDINE-5-METHANOL

Order 302-95-4 Sodium deoxycholate

Order 2438-80-4 6-deoxy-L-Galactose L-(-)-FUCOSE

Order 34454-99-4 1,1,2,2,3,3,4,4,4-nonafluoro-N-2-hydroxyethyl-butane-1-sulfonamide

Order 109-03-5 1,4-Oxathiane 4-oxide

169812-23-1 phenylalaninamide,mercaptoacetyl,leucyl,methyl,169812-23-1

2025-06-13 Discover L-Phenylalaninamide, N-(mercaptoacetyl)-L-leucyl-N-methyl- (CAS No: 169812-23-1) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.